Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference44 articles.
1. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572
2. Abdel-Wahab AF, Mahmoud W, Al-Harizy R (2016) Comparative renal protective effects of canagliflozin and telmisartan in a rat model of diabetic nephropathy. J Nephrol Renal Ther 2:010
3. Akmal M (2001) Hemodialysis in diabetic patients. Am J Kidney Dis 38(4):S195–S199.
https://doi.org/10.1053/ajkd.2001.27443
4. Chao EC (2014) SGLT-2 inhibitors: a new mechanism for glycemic control. Clin Diabet 32(1):4–11.
https://doi.org/10.2337/diaclin.32.1.4
5. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4–7
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献